Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (121-130 of 287) with videos related to

Pageof 29
Sort By:
British Journal of Cancer|April 1, 1995
Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen aloneP Lissoni, S Barni, S Meregalli, et al.
Oncology|July 1, 1994
Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 aloneP Lissoni, S Barni, M Cazzaniga, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 1993
Respiratory distress syndrome in patients with advanced cancer treated with pentoxifylline: a randomized studyA Ardizzoia, P Lissoni, G Tancini, et al.
Tumori|October 31, 1993
Immunotherapy with low-dose subcutaneous interleukin-2 plus beta-interferon as a second-line therapy for metastatic colorectal carcinomaS Barni, P Lissoni, A Ardizzola, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1989
Alterations of pineal gland and of T lymphocyte subsets in metastatic cancer patients: preliminary resultsP Lissoni, G Tancini, S Barni, et al.
Journal of Pineal Research|November 1, 1996
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanomaP Lissoni, O Brivio, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1996
Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptopholP Lissoni, S Pittalis, F Rovelli, et al.
In Vivo (Athens, Greece)|March 27, 2003
Clinical and biological effects of interleukin-2 with or without a concomitant administration of granulocyte-macrophage colony-stimulating factor in metastatic cancer patientsP Lissoni, S Mengo, R Bucovec, et al.
The International Journal of Biological Markers|February 24, 2001
Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancerP Lissoni, E Fugamalli, F Malugani, et al.
Journal of Biological Regulators and Homeostatic Agents|April 7, 2004
A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patientsG Messina, P Lissoni, E Bartolacelli, et al.
Pageof 29

Showing results (121-130 of 287) with videos related to

Sort By:
Pageof 29
British Journal of Cancer|April 1, 1995
Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen aloneP Lissoni, S Barni, S Meregalli, et al.
Oncology|July 1, 1994
Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 aloneP Lissoni, S Barni, M Cazzaniga, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 1993
Respiratory distress syndrome in patients with advanced cancer treated with pentoxifylline: a randomized studyA Ardizzoia, P Lissoni, G Tancini, et al.
Tumori|October 31, 1993
Immunotherapy with low-dose subcutaneous interleukin-2 plus beta-interferon as a second-line therapy for metastatic colorectal carcinomaS Barni, P Lissoni, A Ardizzola, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1989
Alterations of pineal gland and of T lymphocyte subsets in metastatic cancer patients: preliminary resultsP Lissoni, G Tancini, S Barni, et al.
Journal of Pineal Research|November 1, 1996
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanomaP Lissoni, O Brivio, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1996
Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptopholP Lissoni, S Pittalis, F Rovelli, et al.
In Vivo (Athens, Greece)|March 27, 2003
Clinical and biological effects of interleukin-2 with or without a concomitant administration of granulocyte-macrophage colony-stimulating factor in metastatic cancer patientsP Lissoni, S Mengo, R Bucovec, et al.
The International Journal of Biological Markers|February 24, 2001
Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancerP Lissoni, E Fugamalli, F Malugani, et al.
Journal of Biological Regulators and Homeostatic Agents|April 7, 2004
A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patientsG Messina, P Lissoni, E Bartolacelli, et al.
Pageof 29